Hyperkalemia and Heart Failure: Recognizing Risks and Exploring Strategies for Improving Outcomes

February 24, 2019

In this program, Dr. Paul Hauptman and Dr. Javed Butler will 1) describe the relationship between RAAS inhibitors, hyperkalemia, and cardiovascular risk, 2) identify goals and treatments for acute, intermediate, and chronic management, and 3) discuss the clinical profi les of, and clinical settings for the use of, new potassium binders.

CME 1.00 Credits

LDL-Cholesterol Lowering and Atherosclerotic Cardiovascular Disease Risk Reduction: Exploring the Evidence With Non-Statin Therapy

June 17, 2018

n this program, lipid experts will present, in state-of-the-art lectures and in 'realworld' interactive cases, optimal strategies and provide 'take-home' messages for reducing risk in patients with elevated LDL-C.

CME 2.00 Credits

Improving Outcomes in Patients with Elevated LDL-Cholesterol: A Case-Based Series

January 01, 2018

An informative expert series of lectures including cases with the goal of improving outcomes in patients with elevated LDL-cholesterol

No Credit Available

Demystifying Narcolepsy in Children: Pathways to Successful Outcomes

November 15, 2017

In this symposium, experts will address best practices in the diagnosis and treatment of narcolepsy, and explore hypersomnia mimics of narcolepsy in children.

CME 2.00 Credits

Heart Failure Management: Exploring Best Practices for the Internist

September 26, 2017

Experts Dr. Javed Butler and Dr. James Januzzi provide helpful insights on the topic of Heart Failure and offer best practices on heart failure management.

No Credit Available

Management of Narcolepsy and excessive Daytime Sleepines in Obstructive Sleep Apnea

August 09, 2017

In this program, sleep experts including Richard Bogan, MD (Chair), and Suresh Kotagal, MBBS provide valuable insights and best practices for diagnosing and treating narcolepsy in children and adults. Case Studies and in depth participation by Atul Malhotra, MD, Patrick Strollo Jr., MD, and Lisa Collins, RRT, RPSGT, RCP

No Credit Available

LDL Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: EMERGING INSIGHTS

April 08, 2017

In this program, Dr. Lynn Braun and Dr. Michael Miller present lectures and case studies addressing the management of atherosclerotic cardiovascular disease along with best practices and treatment options.

No Credit Available

The Perfect Storm of Heart Failure and Diabetes: Insights into Pathophysiology and Evidence-Based Treatment Strategies

November 08, 2016

In this educational initiative, experts will address the needs of cardiologists for 1) a grasp of the relationship between DM and HF and the pathophysiology of HF in DM, 2) an explanation of clinical evidence for HF drugs in patients with DM, and 3) an assessment of the profiles of traditional and newer antidiabetic agents in patients with/at risk for cardiovascular disease and interpretation of heart failure-related outcomes.

No Credit Available

Optimizing Outcomes in the Management of Narcolepsy and Obstructive Sleep Apnea

October 25, 2016

In this program, Michael Thorpy, MD and Phyllis Zee, MD, provide state-of-the-art lectures, a stimulating panel discussion, and a provocative case study to address the challenges in the diagnosis of narcolepsy.

No Credit Available

Optimizing Management of Recurrent Angina after PCI

May 08, 2015

Deepak Bhatt, MD, MPH, FSCAI (Chair); Duane Pinto, MD, FSCAI and Peter Stone, MD, MPH conduct a state-of-the-art discussion and case study on recurrent angina after PCI

No Credit Available

Demystifying Hypertriglyceridemia: Taking a Closer Look at Pathophysiology, Etiology, and Treatment

April 29, 2015

Eliot Brinton, MD and Terry Jacobson, MD discuss the pathophysiology, etiology, and treatment of hypertriglyceridemia.

No Credit Available